Integrated genomic analyses in PDX model reveal a cyclin-dependent kinase inhibitor Palbociclib as a novel candidate drug for nasopharyngeal carcinomaCheng-Lung Hsu, Hsin-Pai Li, Li‐Yu Lee et al.|Journal of Experimental & Clinical Cancer Research|2018Cited by 36
The branched N-glycan of PD-L1 predicts immunotherapy responses in patients with recurrent/metastatic HNSCCHuai‐Cheng Huang, Pei‐Jen Lou, Yenlin Huang et al.|Oncogenesis|2024Cited by 6
Additional file 4: of Integrated genomic analyses in PDX model reveal a cyclin-dependent kinase inhibitor Palbociclib as a novel candidate drug for nasopharyngeal carcinomaCheng‐Lung Hsu, Hsin-Pai Li, Kar‐Wai Lui et al.|Figshare|2018Cited by 0